4.2.2.1Vertical

Detox & Medical Withdrawal Programs

Medically supervised detoxification and withdrawal management services.

Market snapshot

These figures describe Addiction & Substance Use Treatment (4.2.2), the segment that Detox & Medical Withdrawal Programs sits within — not Detox & Medical Withdrawal Programs on its own.

FragmentationConsolidatingEstimate

No single discrete Census NAICS code — addiction treatment spans outpatient centers (621420), residential (623220), and hospitals (622210), so the segment is not separately sized by the Census Bureau.

Business model & economics

Revenue model

Per-diem residential, outpatient, and MAT reimbursement

Key economics

Recurring revenue
Moderate–High

recurring MAT and outpatient care

EBITDA margin
12–22%
Capex intensity
Moderate

Characteristics

  • Demand driven by the opioid and addiction crisis.
  • MAT expanded evidence-based, recurring treatment.
  • Fraught history of scandals and quality concerns.

M&A deal context

Deal activityHigh

Who’s acquiring

  • PE-backed treatment platforms
  • MAT and outpatient consolidators
  • Behavioral-health operators

What’s driving deals

  • Consolidation of treatment providers.
  • Opioid-crisis and addiction demand.
  • Regulatory and reputational scrutiny.

Find Detox & Medical Withdrawal Programs acquisition targets

Search Acquisera’s index for companies classified under Detox & Medical Withdrawal Programs (4.2.2.1) and build a targeted deal pipeline.

Search companies